1999年至2019年美国各州及种族前列腺癌死亡率趋势:基于疾病控制中心WONDER数据库的估计
研究基于美国CDC WONDER数据库,比较1999至2019年各州及种族前列腺癌年龄标准化死亡率趋势。全国范围内黑人、亚裔、白人及美洲印第安/阿拉斯加原住民男性死亡率均下降,但2019年黑人男性死亡率仍显著高于白人、美洲印第安/阿拉斯加原住民及亚裔男性。2012年USPSTF指南变更后许多州死亡率上升,提示需加强前列腺癌筛查教育。
要点
- 1999至2019年全国前列腺癌年龄标准化死亡率在黑人、亚裔、白人及美洲印第安/阿拉斯加原住民男性中均下降。
- 2019年黑人男性年龄标准化死亡率(13.4/10万)显著高于白人(7.3/10万)、美洲印第安/阿拉斯加原住民(3.2/10万)及亚裔男性(3.2/10万)(p<0.001)。
- 2012年USPSTF指南变更后,许多州年龄标准化死亡率上升,提示需加强优化前列腺癌筛查的教育。
核心结论
- 过去20年所有州所有种族前列腺癌死亡率均下降,提示管理策略进步;尽管黑人男性死亡率下降幅度更大,但其死亡率仍更高;2012年USPSTF指南变更后许多州死亡率上升,提示需加强优化前列腺癌筛查的教育。
研究设计与样本
- 基于美国疾病控制中心(CDC)WONDER数据库提取ICD-10编码C61的前列腺癌死亡率数据,按种族和州分析1999至2019年年龄标准化死亡率(ASMR)趋势;因许多州数据缺乏,仅对白人男性和黑人男性使用Joinpoint回归进行趋势比较。
主要发现
- 1999至2019年全国年龄标准化死亡率下降:黑人男性下降44.6%,亚裔男性下降44.8%,白人男性下降31.8%,美洲印第安或阿拉斯加原住民男性下降19.0%。
- 所有州两种种族的年龄标准化死亡率均下降;白人男性最大降幅在肯塔基州(-47.0%),黑人男性最大降幅在特拉华州(-57.8%)。
- 2019年黑人男性年龄标准化死亡率(13.4/10万)显著高于白人男性(7.3/10万)、美洲印第安或阿拉斯加原住民男性(3.2/10万)及亚裔男性(3.2/10万)(p<0.001)。
- 黑人男性年龄标准化死亡率最高在内布拉斯加州(33.5/10万),白人男性最高在阿拉斯加州(11/10万)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the United States of America (USA), prostate cancer (PC) is the most common cancer in men and the second cause of cancer mortality. Black men (BM) have a higher incidence and worse mortality when compared to white men (WM). We compared trends in PC mortality in the USA by race and state from 1999 to 2019. METHODS: We extracted PC mortality data from the Centers for Disease Control (CDC) WONDER database using the International Classification of Diseases (ICD) 10 code C61. Age-Standardized Mortality Rates (ASMR) were divided into racial groups and reported by year and state. Due to the lack of available data in many states, analyses were conducted only for WM and BM using Joinpoint regression for trend comparisons. RESULTS: Between 1999-2019, ASMR decreased at the national level in Black (-44.6%), Asian (-44.8%), White (-31.8%), and American Indian or Alaskan native men (-19.0%). ASMR decreased in all states for both races. The greatest drop in ASMR was in Kentucky (-47.0%) for WM and Delaware (-57.8%) for BM. In 2019, ASMRs in BM (13.4/100 000) were significantly higher than WM (7.3/100 000), American Indian or Alaskan Native (3.2/100 000), and Asian men (3.2/100 000) (p < 0.001). The highest ASMRs were in Nebraska (33.5/100 000) for BM and Alaska (11/100 000) for WM. CONCLUSIONS: During the last 20 years, the PC mortality rate dropped in all states for all races, suggesting an advancement in management strategies. Although a higher decrease in ASMR was observed in BM, ASMR remain higher among BM. ASMRs were also found to be increasing in many states post USPSTF guideline change (2012), indicating a need for more education around optimized prostate cancer screening.
引用
- Jani C, Mouchati C, Abdallah N, et al. Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database. Prostate Cancer Prostatic Dis. 2022. PMID: 36522462. doi:10.1038/s41391-022-00628-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。